Manulife (Manufacturers Life Insurance)
CAPR icon

Manulife (Manufacturers Life Insurance)’s Capricor Therapeutics CAPR Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$355K Buy
11,684
+78
+0.7% +$2.08K ﹤0.01% 2289
2025
Q4 		$335K Sell
11,606
-1,306
-10% -$17.1K ﹤0.01% 2323
2025
Q3 		$93.1K Sell
12,912
-1,249
-9% -$9.2K ﹤0.01% 2792
2025
Q2 		$141K Buy
14,161
+1,199
+9% +$12.7K ﹤0.01% 2678
2025
Q1 		$123K Buy
12,962
+43
+0.3% +$597 ﹤0.01% 2647
2024
Q4 		$178K Buy
12,919
+2,361
+22% +$41.4K ﹤0.01% 2666
2024
Q3 		$161K Buy
+10,558
New +$52.2K ﹤0.01% 2741

Other funds holding CAPR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s CAPR Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Capricor Therapeutics (CAPR) stake by 0.67% in Q1 2026, buying an estimated $2.08K and bringing the position to 11,684 shares worth $355K. The position accounts for ﹤0.01% of the portfolio, ranked #2289.

Manulife (Manufacturers Life Insurance) first reported a position in CAPR in Q3 2024 and has held it in 7 quarters since. 177 funds tracked by Wall St. Rank hold CAPR as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 11,684 shares of Capricor Therapeutics worth $355K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) bought 78 Capricor Therapeutics shares in Q1 2026, an estimated $2.08K.
  • Capricor Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2289 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Capricor Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • 177 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.